{
  "hash": "49d9440bed2e9cad13510c63281cf30b",
  "result": {
    "markdown": "---\ntitle: Biological interpretation\nbibliography: course_refs.bib\neditor_options: \n  chunk_output_type: console\n---\n\n\n::: {.callout-tip}\n#### Learning Objectives\n\n* Be aware of different analyses that can be done to gain a biological understanding of expression proteomics results\n* Understand the concept of Gene Ontology (GO) enrichment analyses \n* Complete GO enrichment analyses using the `enrichGO` function from the `clusterProfiler` package\n\n:::\n\n\n::: {.cell layout-align=\"center\"}\n::: {.cell-output-display}\n![](figs/flow_chart/flow_chart.012.png){fig-align='center' width=90%}\n:::\n:::\n\n\n\n\n\n## Adding metadata to our results using `dplyr`\n\nBefore we can look any further into the biological meaning of any protein \nabundance changes we need to extract these proteins from our overall results.\nIt is also useful to re-add information about the master protein descriptions\nsince this is lost in the output of `limma` analysis. \n\nIt is important to note that the results table we have generated from `limma`\nis not in the same order as the input data. Therefore, to add information from our\noriginal data e.g., from the `rowData` such as the `Master.Protein.Descriptions`\nwe must match the protein names between them. \n\nTo do this, let's extract information the `Master.Protein.Descriptions` from the original\ndata we have created called `all_proteins`. \n\nRecall that `all_protiens` is `SummarizedExperiment` object,\n\n\n::: {.cell}\n\n```{.r .cell-code}\nall_proteins\n```\n\n::: {.cell-output .cell-output-stdout}\n```\nclass: SummarizedExperiment \ndim: 3823 6 \nmetadata(0):\nassays(2): assay aggcounts\nrownames(3823): A0A0B4J2D5 A0A2R8Y4L2 ... Q9Y6X9 Q9Y6Y8\nrowData names(21): Checked Tags ... Protein.FDR.Confidence .n\ncolnames(6): M_1 M_2 ... G1_2 G1_3\ncolData names(4): sample rep condition tag\n```\n:::\n:::\n\n\nWe wish to extract information from the `rowData` regarding the\n`Master.Protein.Descriptions`,\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## Add master protein descriptions back\nprotein_info <- all_proteins %>%\n  rowData() %>%\n  as_tibble() %>%\n  select(Protein = Master.Protein.Accessions, \n         protein_description = Master.Protein.Descriptions)\n\nprotein_info %>% head()\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 6 × 2\n  Protein    protein_description                                                \n  <chr>      <chr>                                                              \n1 A0A0B4J2D5 Putative glutamine amidotransferase-like class 1 domain-containing…\n2 A0A2R8Y4L2 Heterogeneous nuclear ribonucleoprotein A1-like 3 OS=Homo sapiens …\n3 A0AVT1     Ubiquitin-like modifier-activating enzyme 6 OS=Homo sapiens OX=960…\n4 A0MZ66     Shootin-1 OS=Homo sapiens OX=9606 GN=SHTN1 PE=1 SV=4               \n5 A1L0T0     2-hydroxyacyl-CoA lyase 2 OS=Homo sapiens OX=9606 GN=ILVBL PE=1 SV…\n6 A1X283     SH3 and PX domain-containing protein 2B OS=Homo sapiens OX=9606 GN…\n```\n:::\n:::\n\n\nNote, we also extract the `Master.Protein.Accessions` column so we can use\nthis to match to the `protein` column in our `limma` results.\n\nNow we can use the `left_join` function from `dplyr` to match the protein\ndescriptions to the protein IDs,\n\n\n::: {.cell}\n\n```{.r .cell-code}\nlimma_results <- limma_results %>% \n  left_join(protein_info, by = \"Protein\")\n\n# Verify\nlimma_results %>%\n  head()\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n  Protein     logFC     AveExpr         t      P.Value    adj.P.Val        B\n1  Q9BW19 -2.273445 -0.48781151 -31.31920 3.266414e-10 6.815267e-07 14.02110\n2  Q9NQW6 -2.049413 -0.16777937 -30.27752 4.367177e-10 6.815267e-07 13.77369\n3  Q9ULW0 -2.163283  0.21676121 -29.57100 5.348104e-10 6.815267e-07 13.59880\n4  P49454 -1.806194 -0.09474064 -28.54660 7.236533e-10 6.916316e-07 13.33444\n5  O14965 -2.029577 -0.20204374 -25.55178 1.869711e-09 1.110705e-06 12.48016\n6  P53350 -1.520595  0.06838699 -25.00830 2.247106e-09 1.110705e-06 12.31069\n  direction significance\n1      down          sig\n2      down          sig\n3      down          sig\n4      down          sig\n5      down          sig\n6      down          sig\n                                                             protein_description\n1          Kinesin-like protein KIFC1 OS=Homo sapiens OX=9606 GN=KIFC1 PE=1 SV=2\n2                              Anillin OS=Homo sapiens OX=9606 GN=ANLN PE=1 SV=2\n3          Targeting protein for Xklp2 OS=Homo sapiens OX=9606 GN=TPX2 PE=1 SV=2\n4                Centromere protein F OS=Homo sapiens OX=9606 GN=CENPF PE=1 SV=3\n5                     Aurora kinase A OS=Homo sapiens OX=9606 GN=AURKA PE=1 SV=3\n6 Serine/threonine-protein kinase PLK1 OS=Homo sapiens OX=9606 GN=PLK1 PE=1 SV=1\n```\n:::\n:::\n\n\n::: {.callout-note}\n#### Manipulating data with `dplyr` and `tidyverse`\nThere is lots of information online about getting started with `dplyr` and\nusing the `tidyverse`. We really like [this lesson from the Data Carpentry](https://datacarpentry.org/R-ecology-lesson/03-dplyr.html) if\nyou are new to the `tidyverse`.\n\n:::\n\n## Subset differentially abundant proteins\n\nLet's subset our results and only keep proteins which have been flagged as \nexhibiting significant abundance changes, \n\n\n::: {.cell}\n\n```{.r .cell-code}\nsig_changing <- limma_results %>% \n  as_tibble() %>%\n  filter(significance == \"sig\")\n\nsig_up <- sig_changing %>%\n  filter(direction == \"up\")\n\nsig_down <- sig_changing %>%\n  filter(direction == \"down\")\n```\n:::\n\n\n\n## Biological interpretation of differentially abundant proteins\n\nOur statistical analyses provided us with a list of proteins that are present\nwith significantly different abundances between M-phase and G1-phase of the cell \ncycle. We can get an initial idea about what these proteins are and do by \nlooking at the protein descriptions. \n\n\n::: {.cell}\n\n```{.r .cell-code}\n## Look at descriptions of proteins upregulated in M relative to deysnchronized cells\nsig_up %>%\n  pull(protein_description) %>%\n  head()\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n[1] \"Selenoprotein S OS=Homo sapiens OX=9606 GN=SELENOS PE=1 SV=3\"                    \n[2] \"Golgi reassembly-stacking protein 2 OS=Homo sapiens OX=9606 GN=GORASP2 PE=1 SV=3\"\n[3] \"Poly [ADP-ribose] polymerase 2 OS=Homo sapiens OX=9606 GN=PARP2 PE=1 SV=2\"       \n[4] \"Protein-tyrosine kinase 2-beta OS=Homo sapiens OX=9606 GN=PTK2B PE=1 SV=2\"       \n[5] \"Casein kinase I isoform alpha OS=Homo sapiens OX=9606 GN=CSNK1A1 PE=1 SV=2\"      \n[6] \"Density-regulated protein OS=Homo sapiens OX=9606 GN=DENR PE=1 SV=2\"             \n```\n:::\n:::\n\n\nWhilst we may recognise some of the changing proteins, this might be the first\ntime that we are coming across others. Moreover, some protein descriptions \ncontain useful information, but this is very limited. We still want to find out\nmore about the biological role of the statistically significant proteins so that\nwe can infer the potential effects of their abundance changes. \n\nThere are many functional analyses that could be done on the proteins with\ndifferential abundance:\n\n* Investigate the biological pathways that the proteins function within ([KEGG](https://www.genome.jp/kegg/) etc.)\n* Identify potential interacting partners ([IntAct](https://www.ebi.ac.uk/intact/), [STRING](https://string-db.org] etc.))\n* Determine the subcellular localisation in which the changing proteins are found \n* Understand the co-regulation of their mRNAs ([Expression Atlas](https://www.ebi.ac.uk/gxa))\n* Compare our changing proteins to those previously identified in other proteomic\nstudies of the cell cycle\n\n### Gene Ontology (GO) enrichment analysis \n\nOne of the common methods used to probe the biological relevance of proteins\nwith significant changes in abundance between conditions is to carry out Gene\nOntology (GO) enrichment, or over-representation, analysis.\n\nThe Gene Ontology consortium have defined a set of hierarchical descriptions to\nbe assigned to genes and their resulting proteins. These descriptions are split\ninto three categories: cellular components (CC), biological processes (BP) and\nmolecular function (MF). The idea is to provide information about a protein's\nsubcellular localisation, functionality and which processes it contributes to\nwithin the cell. Hence, the overarching aim of GO enrichment analysis is to\nanswer the question:\n\n*\"Given a list of proteins found to be differentially abundant in my phenotype of interest, what are the cellular components, molecular functions and biological processes involved in this phenotype?\".*\n\nUnfortunately, just looking at the GO terms associated with our differentially\nabundant proteins is insufficient to draw any solid conclusions. For example, if\nwe find that 120 of the 353 proteins significantly\ndownregulated in M phase are annotated with the GO term \"kinase activity\", it may\nseem intuitive to conclude that reducing kinase activity is important for the M-phase \nphenotype. However, if 90% of all proteins in the cell were kinases (an extreme\nexample), then we might expect to discover a high representation of the \"kinase\nactivity\" GO term in any protein list we end up with.\n\nThis leads us to the concept of an over-representation analysis. We wish to ask \nwhether any GO terms are over-represented (i.e., present at a higher frequency \nthan expected by chance) in our lists of differentially abundant proteins. In \nother words, we need to know how many proteins with a GO term *could* have\nshown differential abundance in our experiment vs. how many proteins with this\nGO term *did* show differential abundance in our experiment. \n\nWe are going to use a function in R called `enrichGO` from the the\n[`clusterProfiler`](https://bioconductor.org/packages/release/bioc/html/clusterProfiler.html)\n@Yu2012 Bioconductor R package to perform GO enrichment analysis. The package vignette \ncan be found\n[here](https://bioconductor.org/packages/release/bioc/vignettes/clusterProfiler/inst/doc/clusterProfiler.html).\nand full tutorials for using the package [here](https://yulab-smu.top/biomedical-knowledge-mining-book/index.html)\n\n::: {.callout-note}\n#### Annotation packages in Bioconductor\nThe `enrichGO` function uses the [`org.Hs.eg.db`](https://bioconductor.org/packages/release/data/annotation/html/org.Hs.eg.db.html) Bioconductor package that has\ngenome wide annotation for human, primarily based on mapping using Entrez Gene\nidentifiers. It also uses the [`GO.db`](`https://bioconductor.org/packages/release/data/annotation/html/GO.db.html`) package\nwhich is a set of annotation maps describing the entire Gene Ontology assembled using data from GO.\n\n:::\n\nIn the next code chunk we call the `enrichGO` function,\n\n\n::: {.cell}\n\n```{.r .cell-code}\nego_down <- enrichGO(gene = sig_down$Protein,               # list of down proteins\n                     universe = limma_results$Protein,      # all proteins \n                     OrgDb = org.Hs.eg.db,                  # database to query\n                     keyType = \"UNIPROT\",                   # protein ID encoding\n                     pvalueCutoff = 0.05, \n                     qvalueCutoff = 0.05,\n                     ont = \"ALL\",                           # include CC, BP and MF\n                     readable = TRUE)\n```\n:::\n\n\n\nLet's take a look at the output.\n\n\n::: {.cell}\n\n```{.r .cell-code}\nego_down\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n#\n# over-representation test\n#\n#...@organism \t Homo sapiens \n#...@ontology \t GOALL \n#...@keytype \t UNIPROT \n#...@gene \t chr [1:353] \"Q9BW19\" \"Q9NQW6\" \"Q9ULW0\" \"P49454\" \"O14965\" \"P53350\" \"Q02224\" ...\n#...pvalues adjusted by 'BH' with cutoff <0.05 \n#...220 enriched terms found\n'data.frame':\t220 obs. of  10 variables:\n $ ONTOLOGY   : chr  \"BP\" \"BP\" \"BP\" \"BP\" ...\n $ ID         : chr  \"GO:0030198\" \"GO:0043062\" \"GO:0045229\" \"GO:0006635\" ...\n $ Description: chr  \"extracellular matrix organization\" \"extracellular structure organization\" \"external encapsulating structure organization\" \"fatty acid beta-oxidation\" ...\n $ GeneRatio  : chr  \"18/344\" \"18/344\" \"18/344\" \"12/344\" ...\n $ BgRatio    : chr  \"49/3681\" \"49/3681\" \"49/3681\" \"24/3681\" ...\n $ pvalue     : num  1.48e-07 1.48e-07 1.48e-07 3.54e-07 1.19e-06 ...\n $ p.adjust   : num  0.000129 0.000129 0.000129 0.000232 0.000626 ...\n $ qvalue     : num  0.000115 0.000115 0.000115 0.000206 0.000556 ...\n $ geneID     : chr  \"CCN1/COL23A1/COL12A1/QSOX1/APP/LOXL2/FLOT1/LAMC1/ITGB1/MMP2/P4HA1/TGFB2/SERPINH1/PRDX4/COL4A2/ERO1A/FKBP10/COLGALT1\" \"CCN1/COL23A1/COL12A1/QSOX1/APP/LOXL2/FLOT1/LAMC1/ITGB1/MMP2/P4HA1/TGFB2/SERPINH1/PRDX4/COL4A2/ERO1A/FKBP10/COLGALT1\" \"CCN1/COL23A1/COL12A1/QSOX1/APP/LOXL2/FLOT1/LAMC1/ITGB1/MMP2/P4HA1/TGFB2/SERPINH1/PRDX4/COL4A2/ERO1A/FKBP10/COLGALT1\" \"HSD17B4/ACADVL/ECHS1/ACAA2/HADHA/ACADM/HADH/HADHB/ACAT1/ETFA/IVD/ECH1\" ...\n $ Count      : int  18 18 18 12 25 16 12 21 41 12 ...\n#...Citation\n T Wu, E Hu, S Xu, M Chen, P Guo, Z Dai, T Feng, L Zhou, W Tang, L Zhan, X Fu, S Liu, X Bo, and G Yu.\n clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.\n The Innovation. 2021, 2(3):100141 \n```\n:::\n:::\n\n\nThe output of the `enrichGO` function is an object of class `enrichResult` that\ncontains the `ID` and `Description` of all enriched GO terms. There is also \ninformation about which `geneID`s from our significantly downregulated proteins \nare annotated with each of the enriched GO terms. Let's take a look at the \ndescriptions.\n\n\n::: {.cell}\n\n```{.r .cell-code}\nego_down$Description\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n  [1] \"extracellular matrix organization\"                                 \n  [2] \"extracellular structure organization\"                              \n  [3] \"external encapsulating structure organization\"                     \n  [4] \"fatty acid beta-oxidation\"                                         \n  [5] \"response to endoplasmic reticulum stress\"                          \n  [6] \"regulation of nuclear division\"                                    \n  [7] \"fatty acid catabolic process\"                                      \n  [8] \"response to hypoxia\"                                               \n  [9] \"protein maturation\"                                                \n [10] \"fatty acid oxidation\"                                              \n [11] \"lipid oxidation\"                                                   \n [12] \"response to decreased oxygen levels\"                               \n [13] \"regulation of mitotic nuclear division\"                            \n [14] \"wound healing\"                                                     \n [15] \"protein folding\"                                                   \n [16] \"response to oxygen levels\"                                         \n [17] \"organelle fission\"                                                 \n [18] \"nuclear division\"                                                  \n [19] \"response to wounding\"                                              \n [20] \"cell adhesion\"                                                     \n [21] \"cellular lipid catabolic process\"                                  \n [22] \"inner mitochondrial membrane organization\"                         \n [23] \"positive regulation of cell motility\"                              \n [24] \"cell division\"                                                     \n [25] \"positive regulation of locomotion\"                                 \n [26] \"monocarboxylic acid catabolic process\"                             \n [27] \"positive regulation of cell migration\"                             \n [28] \"protein hydroxylation\"                                             \n [29] \"glycoprotein metabolic process\"                                    \n [30] \"mitotic nuclear division\"                                          \n [31] \"regulation of blood coagulation\"                                   \n [32] \"regulation of hemostasis\"                                          \n [33] \"lipid modification\"                                                \n [34] \"gland development\"                                                 \n [35] \"generation of precursor metabolites and energy\"                    \n [36] \"tissue development\"                                                \n [37] \"skeletal system development\"                                       \n [38] \"small molecule metabolic process\"                                  \n [39] \"transmembrane transport\"                                           \n [40] \"fatty acid metabolic process\"                                      \n [41] \"carboxylic acid metabolic process\"                                 \n [42] \"mitochondrial transmembrane transport\"                             \n [43] \"organic acid catabolic process\"                                    \n [44] \"carboxylic acid catabolic process\"                                 \n [45] \"electron transport chain\"                                          \n [46] \"formation of primary germ layer\"                                   \n [47] \"protein glycosylation\"                                             \n [48] \"macromolecule glycosylation\"                                       \n [49] \"negative regulation of multicellular organismal process\"           \n [50] \"mitochondrial membrane organization\"                               \n [51] \"regulation of cell division\"                                       \n [52] \"collagen fibril organization\"                                      \n [53] \"cellular respiration\"                                              \n [54] \"regulation of coagulation\"                                         \n [55] \"regulation of wound healing\"                                       \n [56] \"regulation of cytokinesis\"                                         \n [57] \"lipid metabolic process\"                                           \n [58] \"organic acid metabolic process\"                                    \n [59] \"oxoacid metabolic process\"                                         \n [60] \"cartilage development\"                                             \n [61] \"lipid catabolic process\"                                           \n [62] \"tricarboxylic acid cycle\"                                          \n [63] \"regulation of mitotic sister chromatid separation\"                 \n [64] \"mitotic sister chromatid segregation\"                              \n [65] \"cell migration\"                                                    \n [66] \"protein transmembrane import into intracellular organelle\"         \n [67] \"positive regulation of cell cycle\"                                 \n [68] \"glycosylation\"                                                     \n [69] \"cellular lipid metabolic process\"                                  \n [70] \"aerobic respiration\"                                               \n [71] \"sterol metabolic process\"                                          \n [72] \"mitotic sister chromatid separation\"                               \n [73] \"regulation of chromosome separation\"                               \n [74] \"negative regulation of wound healing\"                              \n [75] \"import into the mitochondrion\"                                     \n [76] \"mitotic spindle assembly checkpoint signaling\"                     \n [77] \"spindle checkpoint signaling\"                                      \n [78] \"positive regulation of cell division\"                              \n [79] \"spindle assembly checkpoint signaling\"                             \n [80] \"mitotic spindle checkpoint signaling\"                              \n [81] \"positive regulation of cytokinesis\"                                \n [82] \"energy derivation by oxidation of organic compounds\"               \n [83] \"mitochondrial translation\"                                         \n [84] \"meiotic nuclear division\"                                          \n [85] \"mitochondrion organization\"                                        \n [86] \"nuclear chromosome segregation\"                                    \n [87] \"chromosome segregation\"                                            \n [88] \"meiotic cell cycle process\"                                        \n [89] \"negative regulation of sister chromatid segregation\"               \n [90] \"negative regulation of mitotic sister chromatid segregation\"       \n [91] \"negative regulation of mitotic nuclear division\"                   \n [92] \"negative regulation of mitotic metaphase/anaphase transition\"      \n [93] \"negative regulation of nuclear division\"                           \n [94] \"negative regulation of chromosome segregation\"                     \n [95] \"negative regulation of metaphase/anaphase transition of cell cycle\"\n [96] \"negative regulation of chromosome separation\"                      \n [97] \"negative regulation of mitotic sister chromatid separation\"        \n [98] \"vascular process in circulatory system\"                            \n [99] \"fatty acid derivative metabolic process\"                           \n[100] \"secondary alcohol metabolic process\"                               \n[101] \"regulation of chromosome segregation\"                              \n[102] \"glycoprotein biosynthetic process\"                                 \n[103] \"cell motility\"                                                     \n[104] \"response to abiotic stimulus\"                                      \n[105] \"liver development\"                                                 \n[106] \"chromosome separation\"                                             \n[107] \"microtubule cytoskeleton organization involved in mitosis\"         \n[108] \"cardiocyte differentiation\"                                        \n[109] \"response to electrical stimulus\"                                   \n[110] \"positive regulation of mitotic sister chromatid separation\"        \n[111] \"endoplasmic reticulum lumen\"                                       \n[112] \"endoplasmic reticulum\"                                             \n[113] \"cell surface\"                                                      \n[114] \"collagen-containing extracellular matrix\"                          \n[115] \"external encapsulating structure\"                                  \n[116] \"extracellular matrix\"                                              \n[117] \"organelle inner membrane\"                                          \n[118] \"mitochondrial membrane\"                                            \n[119] \"mitochondrial matrix\"                                              \n[120] \"mitochondrial inner membrane\"                                      \n[121] \"mitochondrial envelope\"                                            \n[122] \"organelle envelope\"                                                \n[123] \"envelope\"                                                          \n[124] \"endoplasmic reticulum membrane\"                                    \n[125] \"endoplasmic reticulum subcompartment\"                              \n[126] \"nuclear outer membrane-endoplasmic reticulum membrane network\"     \n[127] \"mitochondrial protein-containing complex\"                          \n[128] \"external side of plasma membrane\"                                  \n[129] \"organelle subcompartment\"                                          \n[130] \"basolateral plasma membrane\"                                       \n[131] \"basal plasma membrane\"                                             \n[132] \"basement membrane\"                                                 \n[133] \"endoplasmic reticulum protein-containing complex\"                  \n[134] \"melanosome\"                                                        \n[135] \"pigment granule\"                                                   \n[136] \"platelet alpha granule\"                                            \n[137] \"basal part of cell\"                                                \n[138] \"spindle midzone\"                                                   \n[139] \"Golgi lumen\"                                                       \n[140] \"side of membrane\"                                                  \n[141] \"inner mitochondrial membrane protein complex\"                      \n[142] \"mitochondrial outer membrane translocase complex\"                  \n[143] \"outer mitochondrial membrane protein complex\"                      \n[144] \"endoplasmic reticulum-Golgi intermediate compartment\"              \n[145] \"protein complex involved in cell adhesion\"                         \n[146] \"smooth endoplasmic reticulum\"                                      \n[147] \"nucleoid\"                                                          \n[148] \"mitochondrial nucleoid\"                                            \n[149] \"platelet alpha granule lumen\"                                      \n[150] \"specific granule\"                                                  \n[151] \"secretory granule membrane\"                                        \n[152] \"organellar ribosome\"                                               \n[153] \"mitochondrial ribosome\"                                            \n[154] \"receptor complex\"                                                  \n[155] \"spindle\"                                                           \n[156] \"specific granule membrane\"                                         \n[157] \"outer kinetochore\"                                                 \n[158] \"organelle membrane contact site\"                                   \n[159] \"plasma membrane region\"                                            \n[160] \"spindle pole\"                                                      \n[161] \"mitochondrial outer membrane\"                                      \n[162] \"secretory granule\"                                                 \n[163] \"neuromuscular junction\"                                            \n[164] \"outer membrane\"                                                    \n[165] \"organelle outer membrane\"                                          \n[166] \"midbody\"                                                           \n[167] \"organellar small ribosomal subunit\"                                \n[168] \"mitochondrial small ribosomal subunit\"                             \n[169] \"extracellular matrix structural constituent\"                       \n[170] \"calcium ion binding\"                                               \n[171] \"oxidoreductase activity\"                                           \n[172] \"protein disulfide isomerase activity\"                              \n[173] \"intramolecular oxidoreductase activity, transposing S-S bonds\"     \n[174] \"signaling receptor activity\"                                       \n[175] \"molecular transducer activity\"                                     \n[176] \"glycosaminoglycan binding\"                                         \n[177] \"intramolecular oxidoreductase activity\"                            \n[178] \"integrin binding\"                                                  \n[179] \"collagen binding\"                                                  \n[180] \"isomerase activity\"                                                \n[181] \"extracellular matrix binding\"                                      \n[182] \"carbohydrate binding\"                                              \n[183] \"flavin adenine dinucleotide binding\"                               \n[184] \"heparin binding\"                                                   \n[185] \"protein-disulfide reductase activity\"                              \n[186] \"oxidoreductase activity, acting on a sulfur group of donors\"       \n[187] \"disulfide oxidoreductase activity\"                                 \n[188] \"virus receptor activity\"                                           \n[189] \"exogenous protein binding\"                                         \n[190] \"transmembrane signaling receptor activity\"                         \n[191] \"sulfur compound binding\"                                           \n[192] \"laminin binding\"                                                   \n[193] \"signaling receptor binding\"                                        \n[194] \"metal ion transmembrane transporter activity\"                      \n[195] \"FAD binding\"                                                       \n[196] \"NAD binding\"                                                       \n[197] \"transporter activity\"                                              \n[198] \"monoatomic cation transmembrane transporter activity\"              \n[199] \"inorganic cation transmembrane transporter activity\"               \n[200] \"receptor ligand activity\"                                          \n[201] \"2-oxoglutarate-dependent dioxygenase activity\"                     \n[202] \"transmembrane transporter activity\"                                \n[203] \"monosaccharide binding\"                                            \n[204] \"signaling receptor activator activity\"                             \n[205] \"serine-type endopeptidase inhibitor activity\"                      \n[206] \"microtubule binding\"                                               \n[207] \"vitamin binding\"                                                   \n[208] \"microtubule motor activity\"                                        \n[209] \"signaling receptor regulator activity\"                             \n[210] \"calcium ion transmembrane transporter activity\"                    \n[211] \"electron transfer activity\"                                        \n[212] \"cytoskeletal motor activity\"                                       \n[213] \"growth factor binding\"                                             \n[214] \"inorganic molecular entity transmembrane transporter activity\"     \n[215] \"active transmembrane transporter activity\"                         \n[216] \"endopeptidase inhibitor activity\"                                  \n[217] \"peptidase inhibitor activity\"                                      \n[218] \"protease binding\"                                                  \n[219] \"PDZ domain binding\"                                                \n[220] \"dioxygenase activity\"                                              \n```\n:::\n:::\n\n\nThere is a long list because of the hierarchical nature of GO terms. The results\nof GO enrichment analysis can be visualised in many different ways. For a full\noverview of GO enrichment visualisation tools see [*Visualization of functional enrichment result*](https://yulab-smu.top/biomedical-knowledge-mining-book/enrichplot.html).\n\n\n\n::: {.cell}\n\n```{.r .cell-code}\ndotplot(ego_down, \n        x = \"Count\", \n        showCategory = 15, \n        font.size = 10,\n        color = \"p.adjust\")\n```\n\n::: {.cell-output-display}\n![](07_biological_interpretation_files/figure-html/unnamed-chunk-11-1.png){width=672}\n:::\n:::\n\n\n\n::: {.callout-tip}\n#### Key Points\n\n- Gene ontology (GO) terms described the molecular function (MF), biological processes (BP) and cellular component (CC) of proteins.\n- GO terms are hierarchical and generic. They do not relate to specific biological systems e.g., cell type or condition.\n- GO enrichment analysis aims to identify GO terms that are present in a list of proteins of interest (foreground) at a higher frequency than expected by chance based on their frequency in a background list of proteins (universe). The universe should be a list of all proteins included identified and quantified in your experiment.\n- The `enrichGO` function from the `clusterProfiler` package provides a convenient way to carry out reproducible GO enrichment analysis in R.\n:::\n\n## References {-}\n",
    "supporting": [
      "07_biological_interpretation_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}